Nucleolus, Nucleolar Stress and Cardiovascular Diseases

The nucleolus is recognized as the largest and most architecturally complex membrane-less organelle within the mammalian nucleus, exhibiting pronounced structural dynamics. Notably, this compartment demonstrates exceptional sensitivity to cellular stress; such perturbations frequently culminate in nucleolar stress, a condition characterized by structural disintegration, functional compromise, and organellar destabilization. Nucleolar stress has emerged as a critical paradigm, positing the nucleolus as both a stress sensor and a signaling hub under pathological conditions. Mechanistically, nucleolar stress responses have been demonstrated to exert pleiotropic regulatory effects on cell cycle progression, differentiation and cell fate determination, thereby triggering apoptosis, senescence, or autophagy in stressed cells. The nucleolus, being the principal site of ribosomal biogenesis and cell cycle control, has been implicated in the pathogenesis of cardiovascular disorders. Clinical and experimental evidence consistently reveals distinct nucleolar morphological aberrations and ribosomal dysfunction during cardiovascular stress events, particularly in myocardial infarction and cardiomyopathy. These disruptions have been shown to impair cardiac proteostasis and metabolic homeostasis, consequently exacerbating myocardial dysfunction. Therefore, elucidating the molecular mechanisms underlying stress-induced nucleolar signaling pathways may provide two key translational benefits: the identification of novel diagnostic biomarkers for early cardiovascular disease detection, and the discovery of precision therapeutic targets. Such advancements could substantially refine clinical management strategies and improve patients’ prognoses.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Discovery and Pharmacology
Published
2026-01-29
DOI
https://doi.org/10.53941/ijddp.2026.100002
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nucleolus, Nucleolar Stress and Cardiovascular Diseases

Xiaocen Jin, Xiaolei Yang, Yan Zhang, Rongqian Xu et al.
International Journal of Drug Discovery and Pharmacology
RNA modifications and cancer
article

Nucleolus, Nucleolar Stress and Cardiovascular Diseases

Xiaocen Jin, Xiaolei Yang, Yan Zhang, Rongqian Xu, Yunlong Xia
article en

Abstract

The nucleolus is recognized as the largest and most architecturally complex membrane-less organelle within the mammalian nucleus, exhibiting pronounced structural dynamics. Notably, this compartment demonstrates exceptional sensitivity to cellular stress; such perturbations frequently culminate in nucleolar stress, a condition characterized by structural disintegration, functional compromise, and organellar destabilization. Nucleolar stress has emerged as a critical paradigm, positing the nucleolus as both a stress sensor and a signaling hub under pathological conditions. Mechanistically, nucleolar stress responses have been demonstrated to exert pleiotropic regulatory effects on cell cycle progression, differentiation and cell fate determination, thereby triggering apoptosis, senescence, or autophagy in stressed cells. The nucleolus, being the principal site of ribosomal biogenesis and cell cycle control, has been implicated in the pathogenesis of cardiovascular disorders. Clinical and experimental evidence consistently reveals distinct nucleolar morphological aberrations and ribosomal dysfunction during cardiovascular stress events, particularly in myocardial infarction and cardiomyopathy. These disruptions have been shown to impair cardiac proteostasis and metabolic homeostasis, consequently exacerbating myocardial dysfunction. Therefore, elucidating the molecular mechanisms underlying stress-induced nucleolar signaling pathways may provide two key translational benefits: the identification of novel diagnostic biomarkers for early cardiovascular disease detection, and the discovery of precision therapeutic targets. Such advancements could substantially refine clinical management strategies and improve patients’ prognoses.

International Journal of Drug Discovery and PharmacologyVol. 5(1)
Dalian Medical University (CN), Peking University (CN), First Affiliated Hospital of Dalian Medical University (CN), Affiliated Zhongshan Hospital of Dalian University (CN)
Good health and well-being
Openalex Percentile: Top 74%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.